• Je něco špatně v tomto záznamu ?

Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction

P. Wohlfahrt, J. Nativi-Nicolau, M. Zhang, CH. Selzman, T. Greene, J. Conte, JE. Biber, R. Hess, FL. Mondesir, O. Wever-Pinzon, SG. Drakos, EM. Gilbert, L. Kemeyou, B. LaSalle, BA. Steinberg, RU. Shah, JC. Fang, JA. Spertus, J. Stehlik

. 2021 ; 6 (8) : 957-962. [pub] 20210801

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012324

Grantová podpora
K08 HL136850 NHLBI NIH HHS - United States
K23 HL143156 NHLBI NIH HHS - United States
K23 HL150322 NHLBI NIH HHS - United States
UL1 TR002538 NCATS NIH HHS - United States

Importance: Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that has subsequently normalized. It is unknown whether such LVEF improvement is associated with improvements in health status. Objective: To examine changes in health-related quality of life in patients with heart failure with reduced ejection fraction (HFrEF) whose LVEF normalized, compared with those whose LVEF remains reduced and those with HF with preserved EF (HFpEF). Design, Setting, and Participants: This prospective cohort study was conducted at a tertiary care hospital from November 2016 to December 2018. Consecutive patients seen in a heart failure clinic who completed patient-reported outcome assessments were included. Clinical data were abstracted from the electronic health record. Data analysis was completed from February to December 2020. Main Outcomes and Measures: Changes in Kansas City Cardiomyopathy Questionnaire overall summary score, Visual Analog Scale score, and Patient-Reported Outcomes Measurement Information System domain scores on physical function, fatigue, depression, and satisfaction with social roles over 1-year follow-up. Results: The study group included 319 patients (mean [SD] age, 60.4 [15.5] years; 120 women [37.6%]). At baseline, 212 patients (66.5%) had HFrEF and 107 (33.5%) had HFpEF. At a median follow-up of 366 (interquartile range, 310-421) days, LVEF had increased to 50% or more in 35 patients with HFrEF (16.5%). Recovery of systolic function was associated with heart failure-associated quality-of-life improvement, such that for each 10% increase in LVEF, the Kansas City Cardiomyopathy Questionnaire score improved by an mean (SD) of 4.8 (1.6) points (P = .003). Recovery of LVEF was also associated with improvement of physical function, satisfaction with social roles, and a reduction in fatigue. Conclusions and Relevance: Among patients with HFrEF in this study, normalization of left ventricular systolic function was associated with a significant improvement in health-related quality of life.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012324
003      
CZ-PrNML
005      
20220506131401.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1001/jamacardio.2021.0939 $2 doi
035    __
$a (PubMed)33950162
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wohlfahrt, Peter $u University of Utah School of Medicine, Salt Lake City $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Prague, Czech Republic $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction / $c P. Wohlfahrt, J. Nativi-Nicolau, M. Zhang, CH. Selzman, T. Greene, J. Conte, JE. Biber, R. Hess, FL. Mondesir, O. Wever-Pinzon, SG. Drakos, EM. Gilbert, L. Kemeyou, B. LaSalle, BA. Steinberg, RU. Shah, JC. Fang, JA. Spertus, J. Stehlik
520    9_
$a Importance: Heart failure with recovered ejection fraction (HFrecEF) is a recently recognized phenotype of patients with a history of reduced left ventricular ejection fraction (LVEF) that has subsequently normalized. It is unknown whether such LVEF improvement is associated with improvements in health status. Objective: To examine changes in health-related quality of life in patients with heart failure with reduced ejection fraction (HFrEF) whose LVEF normalized, compared with those whose LVEF remains reduced and those with HF with preserved EF (HFpEF). Design, Setting, and Participants: This prospective cohort study was conducted at a tertiary care hospital from November 2016 to December 2018. Consecutive patients seen in a heart failure clinic who completed patient-reported outcome assessments were included. Clinical data were abstracted from the electronic health record. Data analysis was completed from February to December 2020. Main Outcomes and Measures: Changes in Kansas City Cardiomyopathy Questionnaire overall summary score, Visual Analog Scale score, and Patient-Reported Outcomes Measurement Information System domain scores on physical function, fatigue, depression, and satisfaction with social roles over 1-year follow-up. Results: The study group included 319 patients (mean [SD] age, 60.4 [15.5] years; 120 women [37.6%]). At baseline, 212 patients (66.5%) had HFrEF and 107 (33.5%) had HFpEF. At a median follow-up of 366 (interquartile range, 310-421) days, LVEF had increased to 50% or more in 35 patients with HFrEF (16.5%). Recovery of systolic function was associated with heart failure-associated quality-of-life improvement, such that for each 10% increase in LVEF, the Kansas City Cardiomyopathy Questionnaire score improved by an mean (SD) of 4.8 (1.6) points (P = .003). Recovery of LVEF was also associated with improvement of physical function, satisfaction with social roles, and a reduction in fatigue. Conclusions and Relevance: Among patients with HFrEF in this study, normalization of left ventricular systolic function was associated with a significant improvement in health-related quality of life.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x patofyziologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a hodnocení výsledků péče pacientem $7 D000071066
650    _2
$a prospektivní studie $7 D011446
650    12
$a kvalita života $7 D011788
650    _2
$a obnova funkce $x fyziologie $7 D020127
650    12
$a tepový objem $7 D013318
650    _2
$a dysfunkce levé srdeční komory $x patofyziologie $7 D018487
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nativi-Nicolau, Jose $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Zhang, Mingyuan $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Selzman, Craig H $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Greene, Thomas $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Conte, Jorge $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Biber, Joshua E $u University of Utah School of Medicine, Salt Lake City $u Now with Xcenda, Warrensburg, Missouri
700    1_
$a Hess, Rachel $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Mondesir, Favel L $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Wever-Pinzon, Omar $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Drakos, Stavros G $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Gilbert, Edward M $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Kemeyou, Line $u University of Utah School of Medicine, Salt Lake City
700    1_
$a LaSalle, Bernie $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Steinberg, Benjamin A $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Shah, Rashmee U $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Fang, James C $u University of Utah School of Medicine, Salt Lake City
700    1_
$a Spertus, John A $u Saint Luke's Mid America Heart Institute, Kansas City, Missouri
700    1_
$a Stehlik, Josef $u University of Utah School of Medicine, Salt Lake City $u Division of Cardiovascular Medicine, University of Utah Health, Salt Lake City
773    0_
$w MED00191356 $t JAMA cardiology $x 2380-6591 $g Roč. 6, č. 8 (2021), s. 957-962
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33950162 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131353 $b ABA008
999    __
$a ok $b bmc $g 1789771 $s 1163525
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 6 $c 8 $d 957-962 $e 20210801 $i 2380-6591 $m JAMA cardiology $n JAMA Cardiol $x MED00191356
GRA    __
$a K08 HL136850 $p NHLBI NIH HHS $2 United States
GRA    __
$a K23 HL143156 $p NHLBI NIH HHS $2 United States
GRA    __
$a K23 HL150322 $p NHLBI NIH HHS $2 United States
GRA    __
$a UL1 TR002538 $p NCATS NIH HHS $2 United States
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...